Conference abstractPublished 18 Oct 2017
Cycloartobiloxanthone, extracted from bark of Artocarpus gomezianus, inhibits the migratory behavior of non-small cell lung cancer cells
Chulalongkorn University, Thailand
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lung cancer metastasis is one of the most common causes of cancer death. The process requires tumor cell dissemination, motility, intravasation, and formation of new tumor at different sites. Natural product-derived compounds exhibiting anti-motility effects is of interest as they may serve as promising lead compounds for cancer therapy. This research aimed to investigate the effect of cycloartobiloxanthone, a pure compound isolated from bark of Artocarpus gomezianus on migration and invasion activities of non-small cell lung cancer cells. Cells were treated with various concentrations of the compound to determine cell viability using MTT assay. The migration and invasion of the treated cells were evaluated by wound healing and transwell assays, respectively. Motility-related proteins were investigated by western blotting. Here we found that cycloartobiloxanthone exhibited potent anti-migration and anti-invasion activities tested in lung cancer H460 cells. In addition, results showed that the compound suppressed cell migration by attenuated migration regulatory proteins. Together, the inhibitory activity of cycloartobiloxanthone on lung cancer migration suggests that cycloartobiloxanthone may be suitable for further development for the treatment of cancer metastasis
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Sucharat Tungsukruthai”